Alliance for Regenerative Medicine

The role of ARM in the cell and gene therapy industry 1:04
The role of ARM in the cell and gene therapy industry
Michael Lehmicke • 26 Jan 2022
The impact of COVID-19 on the advanced therapy sector 1:36
The impact of COVID-19 on the advanced therapy sector
Michael Lehmicke • 26 Jan 2022
Looking forward to Advanced Therapies Week 2022 0:38
Looking forward to Advanced Therapies Week 2022
Janet Lynch Lambert • 26 Jan 2022
Addressing labor and educational gaps in the CGT industry 1:18
Addressing labor and educational gaps in the CGT industry
Michael Lehmicke • 26 Jan 2022
Upscaling cell and gene therapy manufacturing 1:18
Upscaling cell and gene therapy manufacturing
Michael Lehmicke • 26 Jan 2022
A 2022 update of the Alliance for Regenerative Medicine 0:52
A 2022 update of the Alliance for Regenerative Medicine
Janet Lynch Lambert • 26 Jan 2022
The need for standardization in cell and gene therapy manufacturing 2:14
The need for standardization in cell and gene therapy manufacturing
Michael Lehmicke • 26 Jan 2022
CMC challenges in cell and gene therapy manufacturing 1:29
CMC challenges in cell and gene therapy manufacturing
Michael Lehmicke • 26 Jan 2022
Addressing issues in the clinical translation of cell & gene therapies 3:07
Addressing issues in the clinical translation of cell & gene therapies
Janet Lynch Lambert • 26 Jan 2022
The GROW Internship Program: Improving the representation of Black employees within the CGT field 2:39
The GROW Internship Program: Improving the representation of Black employees within the CGT field
Janet Lynch Lambert • 26 Jan 2022
The importance of specialty medical centers in delivering ATMPs 1:14
The importance of specialty medical centers in delivering ATMPs
Paige Bischoff • 11 Mar 2021
Looking ahead to the Cell & Gene Meeting on the Mediterranean 2021 1:47
Looking ahead to the Cell & Gene Meeting on the Mediterranean 2021
Mike Lehmicke • 17 Mar 2021
The European cell & gene therapy landscape 1:27
The European cell & gene therapy landscape
Paige Bischoff • 17 Mar 2021
The challenges of CMC in cell and gene therapies 2:05
The challenges of CMC in cell and gene therapies
Mike Lehmicke • 17 Mar 2021
Supporting the future of ATMPs in the EU 2:21
Supporting the future of ATMPs in the EU
Paige Bischoff • 17 Mar 2021
Looking ahead in the cell & gene therapy sector 2:09
Looking ahead in the cell & gene therapy sector
Mike Lehmicke • 17 Mar 2021
The content of VJRegenMed is intended for healthcare professionals